Page last updated: 2024-12-06

sarmazenil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID71231
CHEMBL ID46547
SCHEMBL ID195304
MeSH IDM0268860

Synonyms (27)

Synonym
sarmazenil
CHEMBL46547
ro-153505
sarmazol
ethyl 7-chloro-5-methyl-6-oxo-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
sarmazol [veterinary] (tn)
78771-13-8
sarmazenil (inn)
D08507
f84ae7x24p ,
sarmazenilum [inn-latin]
ethyl 7-chloro-5,6-dihydro-5-methyl-6-oxo-4h-imidazo-(1,5-a)(1,4)benzodiazepine-3-carboxylate
unii-f84ae7x24p
sarmazenil [inn]
sarmazenilum
SCHEMBL195304
DTXSID70229281
ethyl 7-chloro-5,6-dihydro-5-methyl-6-oxo-4h-imidazo[1,5-a][1,4]-benzodiazepine-3-carboxylate
ethyl-7-chloro-5,6-dihydro-5-methyl-6-oxo-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
ethyl 7-chloro-5,6-dihydro-5-methyl-6-oxo-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
WSDBAFQWNWJTNG-UHFFFAOYSA-N
ethyl 7-chloro-5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
HY-100248
CS-0018399
ethyl 7-chloro-5-methyl-6-oxo-5,6-dihydro-4h-benzo[f]imidazo[1,5-a][1,4]diazepine-3-carboxylate
Q7424290
AKOS040742612

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dosage based on experimental studies."( [Clinical investigations of an i.m. combination anesthesia with fentanylclimazolam/xylazine and postoperative i.v. antagonism with naloxone/sarmazenil/yohimbine in guinea pigs].
Brill, T; Erhardt, W; Henke, J; Lendl, C; Matis, U; Otto, K; Roberts, U, 1996
)
0.5
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (17)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Ki0.01210.00020.561410.0000AID40370; AID40371; AID40376; AID40377; AID72132
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)Ki0.00020.00010.739610.0000AID40377
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Ki0.01210.00020.635210.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Ki0.01210.00020.621710.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Ki0.01210.00020.675810.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Ki0.01210.00020.646910.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Ki0.01210.00020.671210.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Ki0.01210.00020.557710.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Ki0.01210.00020.640310.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Ki0.01210.00020.570810.0000AID40370; AID40371; AID40376; AID40377; AID72132
GABA theta subunitRattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Ki0.01210.00020.656110.0000AID40370; AID40371; AID40376; AID40377; AID72132
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID40377Binding affinity for Diazepam sensitive (DS) isoform of the benzodiazepine (Bz) binding site on GABAA receptors1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors.
AID72133Binding affinity against Diazepam sensitive (DS) Gamma-aminobutyric acid A receptor in rat cerebellum.1995Journal of medicinal chemistry, May-12, Volume: 38, Issue:10
Synthesis of novel imidazobenzodiazepines as probes of the pharmacophore for "diazepam-insensitive" GABAA receptors.
AID72132Binding affinity against Diazepam insensitive (DI) Gamma-aminobutyric acid A receptor1995Journal of medicinal chemistry, May-12, Volume: 38, Issue:10
Synthesis of novel imidazobenzodiazepines as probes of the pharmacophore for "diazepam-insensitive" GABAA receptors.
AID233962Ratio of binding affinity against DI Bz receptor to that of DS Bz receptor1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors.
AID40370Displacement of [3H]flunitrazepam from diazepam-insensitive GABA-A benzodiazepine receptor of rat cerebellar membrane1993Journal of medicinal chemistry, Feb-19, Volume: 36, Issue:4
Synthesis and structure-activity relationships of 3,5-disubstituted 4,5-dihydro-6H-imidazo[1,5-a][1,4]benzodiazepin-6-ones at diazepam-sensitive and diazepam-insensitive benzodiazepine receptors.
AID231712Ratio between diazepam-insensitive (DI) site / diazepam-sensitive (DS) site1993Journal of medicinal chemistry, Feb-19, Volume: 36, Issue:4
Synthesis and structure-activity relationships of 3,5-disubstituted 4,5-dihydro-6H-imidazo[1,5-a][1,4]benzodiazepin-6-ones at diazepam-sensitive and diazepam-insensitive benzodiazepine receptors.
AID40371Displacement of [3H]flunitrazepam from diazepam-sensitive GABA-A benzodiazepine receptor of rat cerebellar membrane1993Journal of medicinal chemistry, Feb-19, Volume: 36, Issue:4
Synthesis and structure-activity relationships of 3,5-disubstituted 4,5-dihydro-6H-imidazo[1,5-a][1,4]benzodiazepin-6-ones at diazepam-sensitive and diazepam-insensitive benzodiazepine receptors.
AID40376Binding affinity for Diazepam insensitive (DI) isoform of the benzodiazepine (Bz) binding site on GABAA receptors1993Journal of medicinal chemistry, Jun-25, Volume: 36, Issue:13
Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (72.73)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.96 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.19 (4.65)
Search Engine Demand Index26.67 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other11 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]